News
NeoVac and CPI partner to accelerate next-generation RNA vaccine technology to clinical trials
We’re helping NeoVac fast-track its lipid nanoparticle technology to clinical trials, to make RNA products more transportable, and have fewer side effects.
Dec 13 2022